Termination of 2 Billion Won Treasury Share Acquisition Trust Agreement

REMED terminated a specific money trust agreement for treasury share acquisition on May 20, 2026, with a contract termination amount of 2 billion won
Through the trust agreement, a total of 632,137 common shares (acquisition cost of 1.99 billion won) were acquired, representing 2.05% of total outstanding shares
After trust termination, all treasury shares were transferred to REMED's securities account, converted to holdings under Article 165-3 of the Financial Investment Services and Capital Markets Act